Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap

Online, November 5, 2024 (Newswire.com) - Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) has outlined a five-year roadmap focused on expanding revenue streams and brand presence through a targeted acquisition strategy and a shift toward long-term profitability. Within the first 24 months, BINP plans to acquire revenue-generating websites in the health and wellness sector, with the ultimate goal of achieving a 15% EBITDA margin by year five. Central to this vision is the development and integration of a proprietary AI-driven platform, fully leveraging the capabilities of its recently acquired AI Maverick intellectual property to enhance customer loyalty and attract new audiences.

"Discussions are underway to acquire revenue-generating e-commerce platforms that will benefit significantly from the integration of our proprietary AI Maverick technology," said Wayne Cockburn, CEO of Bionoid Pharma. "These acquisitions are strategically aligned with our vision to create a powerful ecosystem within the health and wellness sector, where AI-driven insights can drive rapid growth and enhanced user engagement. By incorporating AI Maverick, we can provide a personalized, intelligent shopping experience that not only increases customer satisfaction but also accelerates the revenue potential of each acquired platform. This approach supports our long-term objective of establishing Bionoid Pharma as a leader in AI-powered health solutions."

The AI-driven platform at the heart of BINP's growth strategy will feature three core functionalities: a personalized health assistant, a wellness-on-demand locator, and a strategic corporate communications tool. Together, these features are designed to create a highly engaging user experience, fostering both customer satisfaction and investor confidence. The free, downloadable AI app aims to attract millions of users within its first year, leveraging a social media-driven approach to cultivate a loyal community and highlight BINP as a significant player in the health and wellness investment space. This multi-faceted strategy not only positions BINP for substantial growth but also strengthens its commitment to delivering innovative health solutions that inspire long-term loyalty.

For further information, contact:

Wayne Cockburn, CEO
Phone: (905) 505-0770
[email protected]
www.bionoidpharma.com

SOURCE: Bionoid Pharma, Inc.

Source: Bionoid Pharma, Inc.